Satsuma Pharmaceuticals Competitors and Similar CompaniesClear all

Satsuma Pharmaceuticals's competitors and similar companies include Sumitomo Pharma, Joincare, Apotex and Sanofi Pasteur.

	Satsuma Pharmaceuticals Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.	Sumitomo Pharma Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, veterinary medicines, and food additives.	Joincare Joincare (健康元药业集团股份有限公司) is a company that manufactures and supplies pharmaceuticals products.	Apotex Apotex is a company that develops and manufactures pharmaceutical products.	Sanofi Pasteur Sanofi Pasteur is a pharmaceutical company that develops, manufactures, and supplies vaccines.
Founding Date	Founding Date 2016	Founding Date 1897	Founding Date 1992	Founding Date 1974	Founding Date 1989
Type	Type Public	Type Public	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations South San Francisco, US HQ Durham, US	Locations Osaka, JP HQ Jiangsu, CN Shanghai, CN Fukuoka, JP Hiroshima, JP Hyogo, JP Kobe, JP see more	Locations Shen Zhen, CN HQ	Locations Toronto, CA HQ Toronto, CA	Locations Lyon, FR HQ
Employees	Employees 22100% increase	Employees 4,980	Employees 14,350	Employees 6,294	Employees 6,7454% increase
Valuation ($)	Valuation ($) 36.8 m	Valuation ($) 1.4 b	Valuation ($) 3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥453.3b (FY, 2026)	Revenue (est.) ¥14.9b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €2.8b (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods ¥192.3b (FY, 2026)	Cost of goods ¥5.7b (FY, 2025)	Cost of goods N/A	Cost of goods €505m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit ¥267.8b (FY, 2026)	Gross profit ¥9.3b (FY, 2025)	Gross profit N/A	Gross profit €2.3b (FY, 2021)
Net income	Net income ($70.1m) (FY, 2022)	Net income ¥106.9b (FY, 2026)	Net income ¥2.9b (FY, 2025)	Net income N/A	Net income €605m (FY, 2021)